• 4852 Citations
  • 38 h-Index
1989 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

Neoplasms Medicine & Life Sciences
Carcinogenesis Medicine & Life Sciences
Hepatocytes Medicine & Life Sciences
Multistage Model Mathematics
Tumors Chemical Compounds
Toxicity Chemical Compounds
Liver Medicine & Life Sciences
Neuroblastoma Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1989 2019

18 F-FDG PET/CT longitudinal studies in patients with advanced metastatic melanoma for response evaluation of combination treatment with vemurafenib and ipilimumab

Sachpekidis, C., Kopp-Schneider, A., Hakim-Meibodi, L., Dimitrakopoulou-Strauss, A. & Hassel, J. C., Apr 1 2019, In : Melanoma research. 29, 2, p. 178-186 9 p.

Research output: Contribution to journalArticle

Longitudinal Studies
Melanoma
Tomography
Immunotherapy
Disease-Free Survival
3 Citations (Scopus)

68Ga-PSMA PET/CT in the evaluation of bone metastases in prostate cancer

Sachpekidis, C., Bäumer, P., Kopka, K., Hadaschik, B. A., Hohenfellner, M., Kopp-Schneider, A., Haberkorn, U. & Dimitrakopoulou-Strauss, A., Jun 1 2018, In : European Journal of Nuclear Medicine and Molecular Imaging. 45, 6, p. 904-912 9 p.

Research output: Contribution to journalArticle

Prostatic Neoplasms
Neoplasm Metastasis
Bone and Bones
Recurrence
Bone Neoplasms
12 Citations (Scopus)

Absolute number of new lesions on 18F-FDG PET/CT is more predictive of clinical response than SUV changes in metastatic melanoma patients receiving ipilimumab

Anwar, H., Sachpekidis, C., Winkler, J., Kopp-Schneider, A., Haberkorn, U., Hassel, J. C. & Dimitrakopoulou-Strauss, A., Mar 1 2018, In : European Journal of Nuclear Medicine and Molecular Imaging. 45, 3, p. 376-383 8 p.

Research output: Contribution to journalArticle

Fluorodeoxyglucose F18
Melanoma
Immunotherapy
Therapeutics
ipilimumab

Addressing small sample size bias in multiple-biomarker trials: Inclusion of biomarker-negative patients and Firth correction

Habermehl, C., Benner, A. & Kopp-Schneider, A., Mar 1 2018, In : Biometrical Journal. 60, 2, p. 275-287 13 p.

Research output: Contribution to journalArticle

Small Sample Size
Biomarkers
Inclusion
Sample size
Small sample

Assessment of glucose metabolism and cellular proliferation in multiple myeloma: a first report on combined 18F-FDG and 18F-FLT PET/CT imaging

Sachpekidis, C., Goldschmidt, H., Kopka, K., Kopp-Schneider, A. & Dimitrakopoulou-Strauss, A., Jan 1 2018, In : EJNMMI Research. 8, 28.

Research output: Contribution to journalArticle

Fluorodeoxyglucose F18
Multiple Myeloma
Cell Proliferation
Glucose
Bone Marrow